Perspectives On The Adoption Of Fully Closed Processing For Biopharmaceutical Manufacturing

The biopharmaceutical industry is rapidly evolving as drug manufacturers navigate increasingly complex product pipelines and seek production efficiencies to reduce time to market, increase flexibility, and decrease costs. One such strategy and a key enabler that offers substantial advantages for the production of biopharmaceuticals in this dynamic environment is closed processing.

Closed processing involves isolating and containing the process fluid from the surrounding environment and operators. Any addition or removal of materials from the system occurs through specific control points, ensuring the closure is maintained. This bioprocessing approach effectively mitigates the risk of contamination and allows for a reduction in environmental control requirements.

In this market research study, industry experts share their perspectives and plans related to the implementation of fully closed processing. Explore the drivers and challenges of fully closed processing, the evolution towards fully closed processing, and more.